ConvaTec Group PLC (LON:CTEC) Given Consensus Recommendation of "Buy" by Brokerages

Key Points

• Buy consensus: Nine brokerages rate ConvaTec "Buy," with an average 12‑month price target of GBX 319.67 (individual targets cited around GBX 315–340).
• Market and insider context: Shares opened at GBX 210.60, trading below the 50‑day (GBX 230.89) and 200‑day (GBX 234.22) moving averages, and insider Jonny Mason sold 291,149 shares while insiders own 0.95%.

ConvaTec Group PLC (LON:CTEC - Get Free Report) has earned an average rating of "Buy" from the nine brokerages that are presently covering the company, MarketBeat.com reports. Nine equities research analysts have rated the stock with a buy recommendation. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is GBX 319.67.

Several equities research analysts have recently commented on CTEC shares. Citigroup reiterated an "outperform" rating and set a GBX 315 price objective on shares of ConvaTec Group in a research note on Thursday, March 5th. Deutsche Bank Aktiengesellschaft restated a "buy" rating and issued a GBX 315 target price on shares of ConvaTec Group in a research note on Wednesday, April 8th. Jefferies Financial Group reaffirmed a "buy" rating and set a GBX 325 price target on shares of ConvaTec Group in a research report on Friday, April 10th. Stifel Nicolaus reiterated a "buy" rating and set a GBX 315 price target on shares of ConvaTec Group in a research note on Wednesday, March 11th. Finally, Berenberg Bank reissued a "buy" rating and issued a GBX 340 price objective on shares of ConvaTec Group in a report on Tuesday, April 21st.

ConvaTec Group Price Performance

LON CTEC opened at GBX 210.60 on Friday. The firm's fifty day simple moving average is GBX 230.89 and its two-hundred day simple moving average is GBX 234.22. The firm has a market capitalization of £4.12 billion, a P/E ratio of 24.49, a P/E/G ratio of 0.93 and a beta of 0.84. The company has a current ratio of 1.53, a quick ratio of 0.96 and a debt-to-equity ratio of 106.19. ConvaTec Group has a 12-month low of GBX 208.60 and a 12-month high of GBX 311.20.

Insider Activity at ConvaTec Group

In other ConvaTec Group news, insider Jonny Mason sold 291,149 shares of the company's stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of GBX 234, for a total value of £681,288.66. 0.95% of the stock is owned by insiders.

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.